← Back to Search

Behavioral Intervention

SIB-Time Web-Application Tool for Family Relations (SIBTime Trial)

N/A
Waitlist Available
Led By Patricia Vadasy, Ph.D.
Research Sponsored by Oregon Research Behavioral Intervention Strategies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights

SIBTime Trial Summary

This study is evaluating whether a new web-based tool can help siblings of children with special needs.

Eligible Conditions
  • Family Relations
  • Sibling Relations

SIBTime Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child Adjustment & Parent Self-Efficacy Scale (CAPES)
Parenting & Family Adjustment Scales (PAFAS)
Self-Efficacy for Parenting Tasks Index (SEPTI)
+1 more
Secondary outcome measures
Commercial Feasibility
Demographics
Engagement in Target Activities with Child
+2 more

SIBTime Trial Design

1Treatment groups
Experimental Treatment
Group I: SIBTimeExperimental Treatment1 Intervention
50 primary parents will be assessed at enrollment, then provided the SIBTime technology and exposed to the learning routines for 4 weeks, and then re-assessed at 4 weeks (after treatment completion).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SIB-Time Web-Application Tool
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Oregon Research Behavioral Intervention Strategies, Inc.Lead Sponsor
20 Previous Clinical Trials
9,121 Total Patients Enrolled
Patricia Vadasy, Ph.D.Principal InvestigatorOregon Research Behavioral Interventions Strategies, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025